Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
* European shares seen opening higher* AstraZeneca COVID-19 vaccine can be 90% effective* Vaccine shots could reach Americans by mid-December* EuroSTOXX50 futures up 0.4%, FTSE futures up 0.3%* Eyes on flash PMIs Welcome to the home for real-time co...
Read moreLONDON, Nov 23 (Reuters) - British Prime Minister Boris Johnson on Monday hailed the "fantastic" news that AstraZeneca's COVID-19 vaccine developed with the University of Oxford could be up to 90% effective, but said it still would require safety ...
Read moreLONDON, Nov 23 (Reuters) - Britain will seek to start administering a COVID-19 vaccine before Christmas with the bulk of the rollout at the start of the new year, with life getting back to normal after Easter, health minister Matt Hancock said on...
Read more(Fixes typo in quote)LONDON, Nov 23 (Reuters) - Britain will seek to start administering a COVID-19 vaccine before Christmas with the bulk of the rollout at the start of the new year, with life getting back to normal after Easter, health minister ...
Read more(Adds talks with Philippines, WHO comment)By Kate Holton, Josephine Mason and Kate KellandLONDON, Nov 23 (Reuters) - AstraZeneca said on Monday its COVID-19 vaccine was 70% effective in pivotal trials and could be up to 90% effective, giving the wo...
Read more(Adds Boris Johnson, AstraZeneca comment)By Kate Holton, Josephine Mason and Kate KellandLONDON, Nov 23 (Reuters) - AstraZeneca said on Monday its COVID-19 vaccine could be as much as 90% effective, giving the world's fight against the global pande...
Read more(Adds comment from analysts, updates shares)By Kate Holton, Josephine Mason and Kate KellandLONDON, Nov 23 (Reuters) - AstraZeneca said on Monday its COVID-19 vaccine could be as much as 90% effective, giving the world's fight against the global pa...
Read more(Adds more details throughout)By Kate Holton, Josephine Mason and Kate KellandLONDON, Nov 23 (Reuters) - AstraZeneca said on Monday its COVID-19 vaccine could be around 90% effective, giving the world's fight against the global pandemic a new weap...
Read more(Adds details)By Kate Holton and Josephine MasonLONDON, Nov 23 (Reuters) - Britain’s AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side effects, giving the world another importan...
Read more(Adds more details)By Kate Holton, Josephine Mason and Kate KellandLONDON, Nov 23 (Reuters) - AstraZeneca said on Monday its COVID-19 vaccine could be around 90% effective, giving the world another weapon to fight the global pandemic and potential...
Read more(Removes extra words from headline)By Kate Holton and Josephine MasonLONDON, Nov 23 (Reuters) - Britain’s AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side effects.The vaccine de...
Read more(Adds quotes, details)By Kate Holton and Josephine MasonLONDON, Nov 23 (Reuters) - Britain’s AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side effects.The vaccine developed by Ox...
Read more(Adds market reaction)By Kate Holton and Josephine MasonLONDON, Nov 23 (Reuters) - AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side effects, the latest drugmaker to unveil posi...
Read more(Recasts headline and lead)LONDON, Nov 23 (Reuters) - AstraZeneca said on Monday its vaccine for the novel coronavirus, developed along with the University of Oxford, could be around 90% effective under one dosing regimen."This vaccine's efficacy ...
Read moreLONDON, Nov 23 (Reuters) - British Health Secretary Matt Hancock said it was "fantastic news" that data on Monday showed that a COVID-19 vaccine developed by AstraZeneca with Oxford University could be up to 90% effective."These figures ... shows ...
Read more
Last checked at